info@synchemia.com | sales@synchemia.com 
9766925136 
Cobimetinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 2 CAS NO:NA chemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 2 . We supply Cobimetinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines."
Related Products
| CAT No | SRC-N014775 |
| CAS No | NA |
| Mol.F. | C22H23N3O8S |
| Mol.Wt. | 489.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014776 |
| CAS No | NA |
| Mol.F. | C11H13N3O |
| Mol.Wt. | 203.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014777 |
| CAS No | NA |
| Mol.F. | C11H10BrN3O |
| Mol.Wt. | 280.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014778 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 282.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014779 |
| CAS No | NA |
| Mol.F. | C11H11BrN4O2 |
| Mol.Wt. | 311.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014780 |
| CAS No | NA |
| Mol.F. | C14H16BrN3O3 |
| Mol.Wt. | 354.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014781 |
| CAS No | NA |
| Mol.F. | C23H25FN4O2 |
| Mol.Wt. | 408.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014782 |
| CAS No | NA |
| Mol.F. | C14H18N4O |
| Mol.Wt. | 258.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014783 |
| CAS No | NA |
| Mol.F. | C22H28N2O7S |
| Mol.Wt. | 464.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014784 |
| CAS No | NA |
| Mol.F. | C10H6N2O5 |
| Mol.Wt. | 234.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014785 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014786 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O |
| Mol.Wt. | 247.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014787 |
| CAS No | NA |
| Mol.F. | C16H14ClN3O4 |
| Mol.Wt. | 347.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014788 |
| CAS No | NA |
| Mol.F. | C15H14ClN3O2 |
| Mol.Wt. | 303.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014789 |
| CAS No | NA |
| Mol.F. | C17H16ClN3O4 |
| Mol.Wt. | 361.8 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014790 |
| CAS No | NA |
| Mol.F. | C9H13N7O5 |
| Mol.Wt. | 299.2 |
| INV STATUS | UNDER SYNTHESIS |
